Form 8-K - Current report:
SEC Accession No. 0000944809-20-000020
Filing Date
2020-05-15
Accepted
2020-05-15 16:04:42
Documents
14
Period of Report
2020-05-12
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K a8-kpfizer5x12x20.htm   iXBRL 8-K 43853
  Complete submission text file 0000944809-20-000020.txt   185750

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20200512.xsd EX-101.SCH 4456
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opk-20200512_cal.xml EX-101.CAL 638
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opk-20200512_def.xml EX-101.DEF 1488
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20200512_lab.xml EX-101.LAB 26147
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20200512_pre.xml EX-101.PRE 13594
8 EXTRACTED XBRL INSTANCE DOCUMENT a8-kpfizer5x12x20_htm.xml XML 4300
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4138
Opko Health, Inc. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 20884958
SIC: 2834 Pharmaceutical Preparations